chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Incomplete course of vaccination; Developed a raised / rash; Developed a / hot / rash; Developed a / hot / rash; Developed a / very red rash; This case was reported by a consumer via call center representative and described the occurrence of raised rash in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis.   In November 2019, the patient received the 1st dose of Menveo. On an unknown date, the patient received the 2nd dose of Menveo. On an unknown date, 2 days after receiving Menveo and not applicable after receiving Menveo, the patient experienced raised rash, rash, hot feeling in hand, red rash and incomplete course of vaccination. On an unknown date, the outcome of the raised rash, rash, hot feeling in hand and red rash were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the raised rash, rash, hot feeling in hand and red rash to be related to Menveo.  Additional details were provided as follows: The case was reported by patient's mother. Post vaccination the patient developed a raised, hot, very red rash from the shoulder to the elbow.  The exact onset date was not known but the mother said she discovered it 2 days after and it seemed to have already started to heal.  The events took a week to resolve.  The patient did not receive the 2nd dose of Menveo which led to incomplete course of vaccination. The reporter was unable to recall which arm. The reporter consented to follow up.
Information has been received from a physician via a company representative referring to a patient of unknown age and gender. The patient's medical history and concurrent condition were unknown. On an unknown date the patient was vaccinated with a dose of GARDASIL (dose, lot# and route unknown). Concomitant therapy was not reported. On an unknown date the patient fainted after receiving the  GARDASIL.The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I developed Covid arm, with a big lump on the shot spot, and after almost 3 weeks I have some pain and swollen lymphs on my armpit
1 week after injection, a 1.5-inch raised, red bump has appeared at the injection site. Bump is slightly sore to the touch and itches. Applying Benadryl cream to area. No other side effects noted.
Pt c/o feeling dizzy 15 min after administration.  Pt was wearing a double lined cloth mask and says she feels that the dizziness resulted from wearing the mask so long.  Pt felt fine and amb out of tent to remove mask and "get some fresh air."  Pt then amb to car with spouse.
Red, inflamed patch where injection was given. Knot formed at injection site. Intense itching. Told to use BENADRYL cream to control itch and use ice pack for swelling.
This spontaneous report as received from a registered nurse refers to a 12 year old patient (unspecified gender). On 16-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route were not provided) (lot # K008931 exp. 04-MAR-2017; lot # K009482 exp. 06-MAR-2017) which was exposed to below 36F for 361.81 hours. The nurse was requesting assistance in determining revaccination. In addition, excursion below 32F (31.2F) started on 13-JUL-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient presented to the pharmacy and consented to both the Pfizer and fluarix vaccines. Patient received both vaccines. After patient was gone, staff member went upload vaccine to patient profile and noticed patient had already received a dose of fluarix  three weeks prior to this date. The vaccine was processed through insurance both times and resulted in paid claims both times. Staff pharmacist did not notice the patient received it prior to administration. Patient did not experience any adverse effects from having two doses of fluarix
This spontaneous report was received from a 65-year-old female patient regarding herself. The patient was vaccinated with, 0.65 milliliter (ml) ZOSTAVAX (lot # 03668AE, expiration date 23-MAR-2013) subcutaneously on 15-SEP-2012. The patient did not have any pertinent medical history and drug reactions/allergies. Concomitant medications included sertraline hydrochloride, SINGULAIR, PREMARIN, FLONASE and topiramate. Patient reported that after receiving ZOSTAVAX she developed inflammation in her lower back which spread to her neck on 16-SEP-2012. She stated it was not a rash, but muscle inflammation on 16-SEP-2012. The patient went to her doctor who gave an injection of a muscle relaxant, and also prescribed some pain and anti-inflammatory medication. The patient stated her condition had improved but she had not yet recovered. The events were resolving. Additional information is not expected.
Breakthrough case admission after three doses; patient expired  Moderna 1/26/21 Lot#027L20A;  Moderna 2/23/21 Lot# 011M20A;  Moderna 1/7/22 Lot# 030H21B;
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information has been received on 22-JUL-2014 from a receptionist.  The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 3 months old infant patient of unknown gender. On 04-JUN-2014, the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported, lot#J016188, expiration date 02-OCT-2014) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Arm shot was given in went numb immediately after and stayed numb and felt very heavy for 15 or more minutes.  About an hour later, both legs experienced numbness and weakness.  Next day, still felt numbness in legs and arm. Awoke at night with body aches and general ill feeling. Third day, arm shot was given was achy and numb, had nausea and blurry vision.
This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heartbeat is rising) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced HEART RATE INCREASED (heartbeat is rising). At the time of the report, HEART RATE INCREASED (heartbeat is rising) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not reported. Treatment medication was not reported
The night of - into the day after my first shot I noticed severe body temperature irregularities in my body. It felt like my feet were freezing and my arms/legs were cold and my core was regular temperature. Every time I got up I had extreme hot flashes and heart palpitations. Overall I didn?t experience anything else past a slight headache but the temperature changes were extremely uncomfortable and I went to the ER to be evaluated because I was worried there was something wrong. This feeling lasted for a few weeks.
father states evening of 1SEP pt had fever 101.7, stomach ache, unsteady on feet;father called 911, pt transported to ER;ER report shows viral illness;no refernece to vax rxn;father states it was rxn to vax, wants county to pay med bills;
two Blood Clot; stroke; This is a spontaneous report from a contactable Consumer. This consumer reported for himself that the 78-year-old male patient received bnt162b2 (BNT162B2, COVID 19 Pfizer) at the age of 77-year-old, dose 2 via an unspecified route of administration, administered in Arm Left on 01Jul2021 17:00 (Batch/Lot Number: FA6780) as dose 2, single for covid-19 immunisation. Medical history included high blood pressure, diabetes, arthritis and covid prior vaccination. No Known allergies. Concomitant medications were unknown. The patient previously took first dose of bnt162b2 (BNT162B2, COVID 19 Pfizer, lot Number: EL00185) at the age of 77-year-old on 07Jun202106:15 PM in Left arm for covid-19 immunization. Facility type vaccine was Pharmacy or Drug Store. No other vaccine in four weeks but other medications in two weeks.  The patient experienced two blood clot on 11Jul2021 16:00 with outcome of not recovered, stroke on 11Jul2021 16:00 with outcome of not recovered. The patient was hospitalized for two blood clot and stroke for 17 days. Therapeutic measures were taken as a result of two blood clot, stroke and treatment included Medications. AE resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No covid tested post vaccination.
Pt vaccinated at routine wellness exam 11/4/21. Presented with fever later that day. Pt had episode of eyes rolling back and seizure like activity and proceeded to local emergency department for evaluation following this.
Drooping in face; Numbness traveled from right arm to wrist; Tingling in right arm; Motor and strength issues; A spontaneous report was received from a consumer concerning a 57-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed numbness going from right arm to wrist/ Hypoaesthesia, tingling in right arm/ Paraesthesia, motor and strength issues/ Sensorimotor disorder and drooping in face/facial paralysis.  Medical history or concomitant medications were not reported.  On 09 Mar 2021, the patient received her first planned dose of mRNA-1273 (batch number: not provided) intramuscularly for prophylaxis of COVID-19 infection. Later, she developed numbness in right arm which went up to wrist. She also had tingling in right arm. Moreover, she also reported motor and strength issues along with drooping in face. Treatment information was not provided.  The event drooping in face was considered to be medically significant.  The action taken with mRNA-1273 in response to the events, numbness going from right arm to wrist, tingling in right arm, motor and strength issues and drooping in face, was unknown.  The outcome of the events, numbness going from right arm to wrist, tingling in right arm, motor and strength issues and drooping in face, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Headache Patient started to experience painful dysphagia and pain over left side of head/ear/neck. Narrative:  Employee was sent to the ER from the clinic. She was treated with steroid burst, diphenhydramine and release in stable condition the same day.
Skin itching; Slight tenderness on shoulder; Pimple-like clusters; Allergic reaction; This case was reported by a consumer and described the occurrence of itchy skin in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced itchy skin, shoulder pain, papular rash and allergic reaction. On an unknown date, the outcome of the itchy skin, shoulder pain, papular rash and allergic reaction were unknown.   It was unknown if the reporter considered the itchy skin, shoulder pain, papular rash and allergic reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of the Shingrix vaccine about 3 months ago and for the last 6 weeks patient experienced on and off bouts of skin itching, with slight tenderness, confined to upper back (mainly on my shoulder blades). The area did not have a visible rash, only occasionally some very small pimple like clusters. The patient was doubtful that it was an allergic reaction to any new medicine, food, soap, or clothing as have not  changed any of these variables since before or after receiving the vaccine. The patient did not see delayed itching listed as a side effect for the vaccine but was wondering. If so, would this be a reason not to receive the 2nd dose.
pt was given varicella vax in lt thigh;a raised whelp immed devel surrounded by redness approx 1-2in below inj site;DPH given immed per MD orders;no diff breathing noted;whelp decreasing p/30min;
Felt a slight muscle spasm in the abdomen; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (Felt a slight muscle spasm in the abdomen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 039A21A and 002A21A) for COVID-19 vaccination.     Patient had no allergies. No medical history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination.  The patient's past medical history included COVID-19 (Patient felt woozy, cough for 3 hours straight, went to a sleepy phase, phlegm in the throat. No Hospitalization due to COVID-19. Treated with Claritin and Tylenol.) on 09-Mar-2020 and COVID-19 (No Hospitalization due to COVID-19. No Treatment received.) on 20-Nov-2020.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, the patient experienced MUSCLE SPASMS (Felt a slight muscle spasm in the abdomen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Felt a slight muscle spasm in the abdomen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2020, SARS-CoV-2 test: (Positive) Positive. In November 2020, SARS-CoV-2 test: (Positive) Positive.         No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient was not taking other medications. Patient had no side effect after the 1st and 2nd dose of the vaccine.   This case was linked to MOD-2022-662413 (Patient Link).
Fever, chills, headache,  arm pain and into back and under arm... some stomach issues
A large rash broke on my arm around the vaccination site. The rash was 4 inches by 14 inches. The area is swollen, itchy, hot and red. I applied benadryl gel to the area.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild
pt recvd vax 18OCT93 & 20OCT93 was admitted to the hosp for eval of memory loss & confusion;
Red rash above elbow, all the way around arm. Very hot to the touch and sore.
Around injection site (LT) positive erythema, edema, warmth, tender on palpation. Fever 103.5 degrees). TX BENADRYL 16 mg PO Q8 hours prn Sxs. Good outcome. Sxs started to get better 36 hours after BENADRYL was started and disappeared 48 hours later.
Body aches; Sweats; Chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 07Apr2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to penicillin (MANUFACTURER UNKNOWN). The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 17Mar2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 03:00, approx. 18 hours after the second dose of the vaccine, the patient experienced body aches, sweats, chills and headache. The symptoms lasted for about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of body aches, sweats, chills and headache were resolved on 09Apr2021 at 03:00.  No follow-up attempts are possible. No further information is expected.
Body aches, 2 weeks, arthritis medication meloxicam prescribed knee swelling, 8 days, steroid, muscle relaxer, x rays taken.
Your so-called vaccine which is not a vaccine has killed my brother and my sister; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "Your so-called vaccine which is not a vaccine has killed my brother and my sister". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200037221 same reporter/suspect drug/event, different patient;US-PFIZER INC-PV202200037223 same reporter/suspect drug/event, different patient;; Reported Cause(s) of Death: Your so-called vaccine which is not a vaccine has killed my brother and my sister
gen sz (shaking & eye rolling) x 15-20 seconds-2hr p/vax;no assoc fever;negative past history of neuro problems;
Widespread rash on face, neck, arms, torso back and stomach, red raised itchy. Doesn?t go away with benedryl
- spontaneous nose bleed in right nostril about 17 hours after vaccine.  Applied pressure and tissue, stopped within 10-15 minutes. - metallic taste and dry mouth within 30 minutes of receiving vaccine.  Continued sporadically over next 12 hours.
15 year old patient received the full 1 milliliter dose; This case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 15-year-old male patient who received HAV (Havrix) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   In February 2022, the patient received Havrix 1 ml and Havrix Pre-Filled Syringe Device. In February 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated a 15 year old patient received the full 1 milliliter dose of Havrix this weekend, which led to overdose. The recommended dose for this age was 0.4 milliliter.  The reporter was requesting information regarding potential side effects of the over dose and recommendations for next steps.  The reporter stated that she already reported this event to VAERS. The reporter had not provided additional details. The reporter did not consent to follow-up. The case had been linked to US2022031543, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022031543:same reporter
Patient woke with right sided facial droop, right-sided mouth numbness and whole tongue numbness, and two days of right ear pain. Also, erythematous rash on left arm lasting 5-6 days. CT head unremarkable. MRI brain underway.
Chronic fatigue, rash on neck, chest, swelling on arm, entire shoulder, cough, shortness of breath.
palpitations; heart rate is higher than usual; she was up most of the night; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Sep2021 12:45 (Lot number: FE3592) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies: Sulfur oxide" (unspecified if ongoing), notes: allergic to Sulfur oxide, it's in dried prunes, red wine, it has sulfates, usually she has cough it.; "Allergies: wine" (unspecified if ongoing), notes: She's just allergic to wine; "left ventricular wall leakage", start date: Jun2020 (ongoing), notes: Verbatim: left ventricular wall leak. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1st, LOT: FC3183, Injection, unknown dosage, left upper arm, time: 12:30), administration date: 29Aug2021, when the patient was 69 years old, for Covid-19 immunization, reaction(s): "had a ticklish cough", "kind of like a squeeze in the chest". The following information was reported: PALPITATIONS (non-serious) with onset 28Sep2021, outcome "not recovered", described as "palpitations"; HEART RATE INCREASED (non-serious) with onset 28Sep2021, outcome "not recovered", described as "heart rate is higher than usual"; INSOMNIA (non-serious) with onset Sep2021, outcome "recovered", described as "she was up most of the night". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of palpitations, heart rate increased, insomnia.  Additional information: Caller stated she got her second dose of the Pfizer Covid 19 Vaccine last Monday at noon and experienced palpitations, she said she can breathe but she's just having palpitations. Caller confirmed that she had palpitations; heart rate is higher than usual: Caller stated that the palpitations did not happen right away, it just happened last night, 28Sep2021. Her heart rate is higher than usual, yes its still elevated, for 10 beats at least higher right now. Confirmed palpitations and heart rate being higher was still ongoing, they have gone down a bit, but before midnight, she had the highest, then she was up most of the night, they kind of went down, then she slept a couple of hours, confirmed has improved. Vaccination Facility Type was Pharmacy. History of all previous immunization with the Pfizer vaccine considered as suspect was none. All vaccines administered on same date with the Pfizer vaccine considered as suspect was none. AE(s) did not require a visit to an emergency Room. Patient did not go Physician Office yet; she will call the doctor as soon as possible. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. AE(s) following prior vaccinations was none. Family Medical History Relevant to AE(s) was not provided. Relevant Tests were none.  No follow-up attempts are possible. No further information is expected.
Daptacel mixed with Act HIb and given as 15 month immunization. No problems noted, non reported No treatment.